Lung cancer and chronic obstructive pulmonary disease (COPD) are both leading causes of
death in the world, and these two disease are closely linked in the clinical setting and at the …

Background A two-phase study (clinical and genomic-based) was conducted to evaluate the
effect of timing of chronic obstructive pulmonary disease (COPD) diagnosis on lung cancer …

Chronic obstructive pulmonary disease (COPD) is defined as a disease causing an airflow
limitation that is not fully reversible. COPD is phenotypically complex and characterized by …

Epidemiological studies indicate that tobacco smoke exposure accounts for nearly 90% of
cases of chronic obstructive pulmonary disease (COPD) and lung cancer. However, genetic …

Epidemiological and case–control studies have shown that COPD is an independent risk
factor for lung cancer. The presence of airway obstruction and/or emphysema increases the …

Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary
diseases that commonly coexist and present a number of clinical challenges. COPD confers …

Background Lung cancer is a leading cause of death and hospitalization for patients with
COPD. A detailed understanding of which clinical features of COPD increase risk is needed …

The heritability of chronic obstructive pulmonary disease (COPD) cannot be fully explained
by recognized genetic risk factors identified as achieving genome-wide significance. In …

Lung cancer and chronic obstructive pulmonary disease (COPD) are common pulmonary
disorders. The incidence and clinical course of these two conditions are tightly intertwined in …

Chronic obstructive pulmonary disease (COPD) and lung cancer are common global causes
of morbidity and mortality. Because both diseases share several predisposing risks, the 2 …